View of Comparative Risk of Clinically Significant Bleeding In Patients with Atrial Fibrillation Receiving Factor Xa Inhibitors versus Vitamin K Antagonists: A Case-Control Study

Return to Article Details Comparative Risk of Clinically Significant Bleeding In Patients with Atrial Fibrillation Receiving Factor Xa Inhibitors versus Vitamin K Antagonists: A Case-Control Study Download Download PDF